vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1061 |
4. Check minimum number of eventsNone |
1061 |
5. Include endpointsNone |
1061 |
6. Filter based on genotype QC (FinnGen only) |
1061 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Dementia vascularis subcorticalis
Similar endpoints
↥List of similar endpoints to
Vascular dementia (subcortical)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12884 | 7551 | 5236 |
| Only index persons | 10927 | 6528 | 4399 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.19 | 0.22 | 0.15 |
| Only index persons | 0.21 | 0.24 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 82.23 | 83.77 | 80.07 |
| Only index persons | 82.70 | 84.21 | 80.45 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1061 | 450 | 611 |
| Unadjusted period prevalence (%) | 0.22 | 0.15 | 0.27 |
| Median age at first event (years) | 81.05 | 82.45 | 80.02 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 896
- Matched controls
- 8959
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
746.3
323.0
427
11
F01.2
ICD-10 Finland
Subcortical vascular dementia
786.3
323.0
312
6
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
+∞
300.4
271
*
N06DX01
ATC
memantine; oral
169.6
260.1
264
22
G30.1
ICD-10 Finland
Alzheimer disease with late onset
110.6
216.9
231
28
N06DA02
ATC
donepezil; oral
108.6
163.1
175
20
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.8
156.3
320
403
F03
ICD-10 Finland
Unspecified dementia
41.0
146.1
184
56
F01.9
ICD-10 Finland
Vascular dementia, unspecified
89.1
129.9
143
19
N06DA03
ATC
rivastigmine; oral, transdermal
184.5
123.9
127
8
N05AX08
ATC
risperidone; systemic
12.1
116.1
227
245
P20
ICPC
Memory disturbance
6.7
109.8
333
730
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
94.5
89
*
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
827.3
78.6
76
*
N05AH04
ATC
quetiapine; oral
7.2
78.3
208
359
N06DA04
ATC
galantamine; oral
405.1
76.0
75
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
163.4
72.2
75
5
A28
ICPC
Limited function/disability NOS
4.0
68.4
354
1258
R41.3
ICD-10 Finland
Other amnesia
12.0
59.8
113
106
P70
ICPC
Dementia
26.0
59.2
83
35
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.1
54.5
439
2107
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
59.3
52.3
61
11
R53
ICD-10 Finland
Malaise and fatigue
3.3
51.6
333
1349
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
+∞
44.1
42
*
SPAT1053
SPAT
Memory test
3.1
41.0
285
1179
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.6
37.9
191
619
G30.8
ICD-10 Finland
Other Alzheimer disease
62.8
36.5
42
7
R41.0
ICD-10 Finland
Disorientation, unspecified
6.8
36.4
96
156
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
12.9
35.7
64
53
F05.1
ICD-10 Finland
Delirium superimposed on dementia
54.9
35.7
42
8
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
30.0
32.3
43
15
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
155.0
28.8
30
*
N06AX11
ATC
mirtazapine; oral
2.5
28.7
297
1499
N02BE01
ATC
paracetamol; systemic, rectal
2.6
27.9
742
5855
F01
ICD-10 Finland
Vascular dementia
149.6
27.8
29
*
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
279.0
26.9
27
*
N05BA04
ATC
oxazepam; oral
2.5
26.2
263
1297
N06AB10
ATC
escitalopram; oral
3.2
25.8
148
517
G30
ICD-10 Finland
Alzheimer disease
267.9
25.8
26
*
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
139.0
25.7
27
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
24.6
367
2177
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
128.4
23.7
25
*
L28
ICPC
Limited function/disability (L)
2.4
23.3
235
1152
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
22.3
214
1019
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.0
21.8
91
246
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.9
21.8
148
578
F05.9
ICD-10 Finland
Delirium, unspecified
6.4
21.7
58
96
TAB00
NOMESCO Finland
Lumbar puncture
7.4
20.9
50
71
N05AH03
ATC
olanzapine; systemic
6.6
20.8
54
86
F01.0
ICD-10 Finland
Vascular dementia of acute onset
214.7
20.7
21
*
N03AG01
ATC
valproic acid; systemic, rectal
5.5
20.2
61
118
N06AB04
ATC
citalopram; systemic
2.3
19.1
205
1021
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
18.8
18
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
18.8
205
1029
F06.7
ICD-10 Finland
Mild cognitive disorder
4.9
18.8
62
133
AA1AD
NOMESCO Finland
CT of head and brain
2.1
18.7
285
1660
S01.0
ICD-10 Finland
Open wound of scalp
3.1
18.3
107
374
S06.0
ICD-10 Finland
Concussion
2.9
18.3
120
453
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
18.1
137
568
N06AX26
ATC
vortioxetine; oral
6.5
18.0
47
76
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
17.4
109
402
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
17.2
635
5029
SPAT1216
SPAT
Assessment of functional ability
2.2
17.2
207
1086
R42
ICD-10 Finland
Dizziness and giddiness
2.0
16.9
265
1549
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
16.8
193
989
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
16.8
240
1350
R4110
NOMESCO Finland
Physiotherapy
2.0
16.4
255
1481
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
16.0
74
219
S72.0
ICD-10 Finland
Fracture of neck of femur
3.0
15.6
93
330
J01DB01
ATC
cefalexin; oral
1.8
15.3
626
5015
WYA20
NOMESCO Finland
Home visit
7.7
15.3
35
47
XA800
NOMESCO Finland
Neuropsychological investigation
6.3
14.4
38
63
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
14.3
178
938
U04
ICPC
Incontinence urine
3.2
13.8
75
251
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
76.3
13.6
15
*
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
76.3
13.6
15
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
7.9
13.4
30
39
R55
ICD-10 Finland
Syncope and collapse
2.2
13.4
146
725
A06AD11
ATC
lactulose; oral
1.9
13.2
223
1321
I95.1
ICD-10 Finland
Orthostatic hypotension
3.4
13.1
65
203
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.0
12.8
74
258
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
70.9
12.6
14
*
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
+∞
12.5
12
*
Z02.7
ICD-10 Finland
Issue of medical certificate
3.0
12.4
72
252
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.4
12.4
60
185
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.0
12.2
33
57
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
11.8
77
290
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
11.8
61
197
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
11.8
74
274
Z75.5
ICD-10 Finland
Holiday relief care
7.0
11.7
28
41
F009, G309
ICD-10 Finland
NA
+∞
11.5
11
*
F0019, G301
ICD-10 Finland
NA
+∞
11.5
11
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.1
11.4
44
112
Z3226
NOMESCO Finland
Physiotherapist
1.9
11.4
178
1018
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
11.4
123
606
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.0
11.3
66
233
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
10.7
105
496
Z3231
NOMESCO Finland
Registered nurse
1.7
10.7
262
1740
N06AB06
ATC
sertraline; oral
2.9
10.6
65
236
C10AA01
ATC
simvastatin; oral
1.6
10.6
488
3835
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
10.5
270
1815
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
5.7
10.5
29
52
A04
ICPC
Weakness/tiredness general
2.0
10.4
150
831
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
+∞
10.4
10
*
A29
ICPC
General symptom/complaint other
2.1
10.4
119
603
N02AA05
ATC
oxycodone; systemic
1.8
10.2
179
1065
F21
ICPC
NA
6.0
10.2
27
46
130
Kela drug reimbursment
Malignant tumour
0.3
10.1
16
593
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
10.1
186
1126
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.3
10.0
23
32
SPAT1254
SPAT
Administration of medicine
1.9
10.0
169
990
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
9.7
57
202
N30.0
ICD-10 Finland
Acute cystitis
1.9
9.7
141
785
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
9.6
158
919
ZXA05
NOMESCO Finland
Left side
1.7
9.6
263
1789
G04BD12
ATC
mirabegron; oral
2.1
9.6
113
579
R44.3
ICD-10 Finland
Hallucinations, unspecified
15.2
9.5
15
10
Z2221
NOMESCO Finland
Medical doctor
1.7
9.4
238
1584
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
9.3
130
711
W19
ICD-10 Finland
Unspecified fall
2.2
9.3
98
479
A10AE04
ATC
insulin glargine; parenteral
2.2
9.1
94
454
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.8
8.9
24
42
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
8.9
76
337
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
8.8
393
3016
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
8.8
64
261
ZXD35
NOMESCO Finland
Usual procedure
3.1
8.7
47
159
ZXA00
NOMESCO Finland
Right side
1.6
8.6
274
1931
WX212
NOMESCO Finland
Femoral plexus blockade
3.8
8.5
35
96
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.9
8.5
51
185
C07AB07
ATC
bisoprolol; oral
1.5
8.5
511
4181
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
90.9
8.4
9
*
Y94.0
ICD-10 Finland
Accident at home
4.1
8.4
31
77
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.2
8.3
43
141
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
8.3
53
200
R11
ICD-10 Finland
Nausea and vomiting
2.1
8.2
88
434
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
8.1
142
839
G21.8
ICD-10 Finland
Other secondary parkinsonism
33.7
8.1
10
*
A02BC02
ATC
pantoprazole; systemic
1.5
8.1
517
4263
N05AD01
ATC
haloperidol; systemic
3.0
8.0
43
146
P99
ICPC
Psychological disorders other
7.9
7.9
17
22
G04BD07
ATC
tolterodine; oral
2.2
7.6
75
354
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.5
7.6
33
96
SPAT1360
SPAT
Extensive global examination
2.2
7.5
75
358
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.5
7.5
25
57
EBA00
NOMESCO Finland
Extraction of tooth
1.6
7.5
200
1343
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.7
7.4
48
183
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.7
7.4
30
82
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
+∞
7.3
7
*
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
7.3
7
*
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
7.3
111
627
A98
ICPC
Health maint/preventive medicine
1.5
7.1
638
5571
A23
ICPC
Risk factor NOS
2.8
7.1
42
152
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.3
7.1
34
107
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
7.1
303
2273
S70.0
ICD-10 Finland
Contusion of hip
2.6
7.0
49
195
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
7.0
194
1311
S01
ICD-10 Finland
Open wound of head
5.2
7.0
20
39
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
3.6
6.9
29
82
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.9
176
1163
P29
ICPC
Psychological sympt/compl other
4.4
6.9
23
53
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
4.1
6.8
25
63
G20
ICD-10 Finland
Parkinson disease
2.8
6.8
40
145
C10AA05
ATC
atorvastatin; oral
1.5
6.8
351
2731
R32
ICD-10 Finland
Unspecified urinary incontinence
3.1
6.7
35
117
Y94.8
ICD-10 Finland
Other leisure activity accident
4.0
6.7
25
64
F00
ICD-10 Finland
Dementia in Alzheimer disease
22.7
6.7
9
*
WX110
NOMESCO Finland
Local anesthesy
1.4
6.6
404
3243
A10BA02
ATC
metformin; oral
1.5
6.6
274
2037
ZXE00
NOMESCO Finland
One hour or less
1.5
6.5
308
2349
N30.9
ICD-10 Finland
Cystitis, unspecified
2.1
6.5
67
325
C09AA05
ATC
ramipril; oral
1.5
6.4
280
2097
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.1
6.4
67
326
SPAT1229
SPAT
Assessment of need for aid
1.9
6.4
95
529
K08.3
ICD-10 Finland
Retained dental root
2.2
6.4
60
279
A10BH05
ATC
linagliptin; oral
2.2
6.4
62
292
G72.8
ICD-10 Finland
Other specified myopathies
3.9
6.4
24
62
C02AC05
ATC
moxonidine; oral
2.3
6.4
54
239
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
6.3
363
2872
N06AX21
ATC
duloxetine; oral
2.1
6.3
66
324
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
6.3
123
755
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
+∞
6.3
6
*
J01CA04
ATC
amoxicillin; systemic
1.4
6.2
557
4790
P15
ICPC
Chronic alcohol abuse
7.1
6.2
14
20
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.1
350
2763
Z2445
NOMESCO Finland
Psychologist
4.7
6.1
19
41
Z01.9
ICD-10 Finland
Special examination, unspecified
2.4
6.0
49
212
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.0
114
689
G04BD08
ATC
solifenacin; oral
2.0
6.0
73
381
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
418
1978
2.84
56.32
1.9
1.8
nmol/l
1080.3
1199.1
1.79
318
1455
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
372
1672
2.89
55.03
3.2
3.2
mmol/l
2.5
2.5
0.07
313
1428
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
41
24
17.73
49.91
1.1
1.0
ng/l
54.2
27.4
—
30
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
41
24
17.73
49.91
1.1
1.0
ng/l
577.3
717.1
0.55
27
11
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
40
24
17.28
48.10
1.1
1.0
ng/l
378.7
231.2
—
30
10
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
585
3565
2.43
43.44
2.7
2.2
pmol/l
89.6
91.5
0.44
346
1831
(3024561) Albumin [Mass/volume] in Serum or Plasma
573
3586
2.30
38.31
4.1
4.3
g/l
34.0
33.7
0.61
515
3281
(3015377) Calcium [Moles/volume] in Serum or Plasma
471
2738
2.30
37.30
2.7
3.3
mmol/l
2.4
2.3
0.85
413
2288
(3023368) Bacteria identified in Blood by Culture
461
2660
2.30
37.12
4.4
4.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
43
47
9.49
35.85
2.9
3.3
umol/l
301.9
325.8
0.43
37
40
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
478
2855
2.23
34.80
2.1
2.2
nmol/l
77.0
80.4
1.74
429
2431
(3021960) Folate [Moles/volume] in Serum or Plasma
395
2206
2.26
33.66
1.8
1.6
nmol/l
17.8
20.0
2.03
374
1827
(3026008) Bacteria identified in Urine by Culture
484
3016
2.11
30.47
4.6
3.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
718
5193
2.18
30.39
7.9
5.7
e6/l
5152.2
2461.6
0.34
29
100
(3002582) Erythrocytes [#/volume] in Urine
433
2643
2.08
28.25
4.5
3.6
e6/l
111.3
98.0
0.13
333
2094
(3003338) MCHC [Mass/volume]
695
5040
2.10
28.15
33.5
26.6
g/l
328.5
329.7
2.34
670
4960
(3018095) Leukocytes [#/volume] in Urine
468
2949
2.05
27.90
5.5
4.1
e6/l
284.8
151.0
0.49
335
2224
(3018418) pH of Serum or Plasma
413
2506
2.06
27.13
3.0
3.8
ph
7.4
7.4
0.80
66
495
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
591
4152
1.96
24.81
5.5
6.4
mmol/l
1.2
1.2
0.29
491
3446
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
545
3768
1.92
23.55
4.7
5.7
mmol/l
1.2
1.2
0.50
504
3349
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
399
2500
1.96
23.07
2.3
2.1
u/l
288.9
230.2
0.52
371
2323
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
465
3072
1.91
22.89
4.4
3.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
255
1390
2.10
21.57
4.1
3.2
e6/l
2.3
2.3
0.01
134
802
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
820
6632
2.04
20.76
26.3
19.6
mg/l
30.1
28.7
0.63
741
5619
(3037467) Urinalysis macro (dipstick) panel - Urine
672
5099
1.87
20.50
6.5
5.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
365
2299
1.90
20.20
4.1
3.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
220
1165
2.12
19.93
1.9
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
308
1841
1.95
19.92
3.1
3.1
mosm/kgh2o
560.4
538.0
1.08
254
1557
(3013826) Glucose [Moles/volume] in Serum or Plasma
620
4625
1.82
19.59
5.1
4.7
mmol/l
7.3
7.0
1.32
583
4359
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
745
5907
1.88
19.01
5.2
4.8
mu/l
2.0
2.1
0.54
682
5172
(3030467) Casts [#/volume] in Urine by Automated count
373
2423
1.83
18.35
4.2
3.5
e6/l
0.6
0.6
0.10
281
1893
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
41
87
4.86
18.34
1.4
1.4
e6/l
3.4
24.9
1.13
30
71
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
41
87
4.86
18.34
1.5
1.5
e6/l
210.4
450.0
0.38
31
73
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
300
1841
1.88
17.57
5.2
4.5
ng/l
130.6
270.2
1.27
277
1669
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
395
2658
1.77
16.98
2.7
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
36
74
5.00
16.71
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
213
1184
2.00
16.65
2.0
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
832
6965
1.90
16.31
30.9
24.2
mmol/l
139.2
139.3
0.13
802
6753
(3023103) Potassium [Moles/volume] in Serum or Plasma
832
6971
1.90
16.18
31.1
24.4
mmol/l
4.0
4.0
2.49
801
6753
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
249
1474
1.90
16.12
3.9
3.0
e6/l
1.1
1.6
0.99
125
878
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
272
1671
1.84
15.62
2.0
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
366
2459
1.75
15.51
2.4
2.3
mg/l
3.2
3.3
0.14
312
2075
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
698
5590
1.73
15.37
6.2
7.1
u/l
83.1
84.4
0.20
652
5188
(3007461) Platelets [#/volume] in Blood
832
7018
1.86
15.21
35.1
28.9
e9/l
236.4
233.9
0.49
793
6775
(3000963) Hemoglobin [Mass/volume] in Blood
832
7019
1.86
15.19
35.4
29.1
g/l
125.8
128.8
6.88
804
6855
(3035941) MCH [Entitic mass]
832
7019
1.86
15.19
34.9
28.8
pg
30.3
30.4
0.40
800
6843
(3026361) Erythrocytes [#/volume] in Blood
832
7019
1.86
15.19
35.1
28.9
e12/l
4.2
4.3
4.18
788
6746
(3024731) MCV [Entitic volume]
832
7019
1.86
15.19
35.0
28.8
fl
92.1
92.0
0.22
799
6844
(3010813) Leukocytes [#/volume] in Blood
832
7021
1.86
15.15
35.1
28.9
e9/l
7.5
7.2
1.59
792
6744
(3002385) Erythrocyte distribution width [Ratio]
645
5084
1.69
14.79
32.4
24.1
%
14.3
14.2
1.02
618
4941
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
612
4793
1.65
14.06
3.8
3.8
pmol/l
15.2
15.3
0.21
558
4184
(3000850) Epithelial cells [#/volume] in Urine
299
1942
1.75
14.03
3.1
2.8
e6/l
5.1
4.9
0.19
258
1700
(3009261) Glucose [Presence] in Urine by Test strip
479
3536
1.65
13.84
6.1
4.5
estimate
0.0
0.0
0.00
62
668
(3035350) Ketones [Presence] in Urine by Test strip
474
3497
1.64
13.68
5.9
4.4
estimate
0.0
0.0
0.00
60
681
(3011397) Hemoglobin [Presence] in Urine by Test strip
265
1683
1.77
13.35
4.9
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
784
6632
1.70
12.58
23.3
19.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
674
5491
1.62
12.51
30.3
21.8
%
36.2
36.6
0.49
427
3130
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
523
4022
1.59
12.28
4.1
5.5
umol/l
13.2
13.1
0.04
490
3790
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
478
3602
1.60
12.21
3.1
3.0
u/l
56.1
59.5
0.30
431
3207
(3021601) Nitrite [Presence] in Urine by Test strip
466
3492
1.60
12.18
8.4
6.0
estimate
0.0
0.0
0.00
62
664
(3024354) Oxygen [Partial pressure] in Venous blood
146
792
1.98
12.01
3.1
2.7
kpa
4.1
4.4
1.14
137
753
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
459
2.25
11.84
3.0
3.2
mmol/l
23.9
24.0
0.18
90
411
(3002032) Base excess in Venous blood by calculation
165
946
1.88
11.49
3.6
3.2
mmol/l
1.7
2.0
0.50
138
734
(3023410) Appearance of Cerebral spinal fluid
20
34
5.98
11.35
1.5
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
165
957
1.86
11.06
3.6
3.2
kpa
5.9
5.8
0.29
158
918
(3013650) Neutrophils [#/volume] in Blood by Automated count
516
4019
1.55
11.04
5.5
7.7
e9/l
4.9
4.4
3.43
416
3471
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
793
6823
1.64
10.89
10.4
11.1
u/l
21.2
23.1
1.74
755
6487
(3033658) Prothrombin time (PT) actual/Normal
282
1913
1.65
10.84
3.7
3.9
%
75.2
79.4
1.98
274
1859
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
65
265
2.55
10.69
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
65
265
2.55
10.69
1.4
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
451
3438
1.54
10.45
4.5
4.9
e9/l
0.0
0.0
0.22
358
2897
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
107
547
2.06
10.35
1.5
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
448
3418
1.54
10.30
4.5
4.9
e9/l
0.7
0.6
1.44
356
2867
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
125
684
1.94
9.98
2.7
2.3
u/l
29.1
34.0
0.76
106
576
(3019198) Lymphocytes [#/volume] in Blood
454
3503
1.52
9.75
4.6
5.1
e9/l
1.8
1.8
0.23
356
3009
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
71
316
2.34
9.67
1.9
1.6
%
1.6
1.7
0.40
56
248
(3002030) Lymphocytes/100 leukocytes in Blood
434
3325
1.52
9.59
5.0
5.5
%
23.8
24.4
0.44
391
3035
(3012544) pH of Venous blood
163
983
1.78
9.56
3.6
3.2
—
7.4
—
0
5
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
143
830
1.84
9.51
2.0
2.5
umol/l
12.7
10.5
0.31
113
702
(3013707) Erythrocyte sedimentation rate by Westergren method
619
5111
1.51
9.49
3.8
4.2
mm/h
17.4
17.0
0.22
563
4621
(3013115) Eosinophils [#/volume] in Blood
456
3538
1.51
9.45
4.7
5.1
e9/l
0.2
0.2
0.79
364
3020
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
121
670
1.91
9.32
1.5
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
424
3261
1.50
9.06
4.8
5.3
%
60.7
60.0
0.55
387
3003
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
18
35
5.21
8.90
3.3
1.8
u/field
1.8
2.4
0.13
13
20
(40758558) Short blood count panel - Blood
252
1754
1.57
8.44
4.8
6.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
421
3270
1.48
8.39
5.2
5.5
%
8.9
9.1
0.36
388
3011
(3006504) Eosinophils/100 leukocytes in Blood
419
3258
1.47
8.28
4.8
5.2
%
2.8
2.8
0.05
382
2989
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
115
654
1.85
8.15
1.9
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
409
3175
1.47
8.10
4.6
5.2
%
0.6
0.6
0.28
376
2919
(3024891) Influenza virus A+B Ag [Presence] in Specimen
48
195
2.53
8.00
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
225
1553
1.57
7.75
6.9
5.0
kg/l
1.0
1.0
0.88
29
261
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
315
2.17
7.65
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
131
790
1.75
7.63
3.8
5.8
mmol/l
1.6
1.4
1.18
125
744
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
263
1886
1.52
7.61
2.0
1.8
pmol/l
437.3
13017786.2
1.06
224
1498
(3007853) Bacteria identified in Skin by Aerobe culture
146
920
1.68
7.25
1.8
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
693
6021
1.44
7.06
25.5
19.3
ml/min/173m2
66.2
65.3
0.57
557
5086
(3024928) Oxygen saturation in Venous blood
45
190
2.43
6.94
1.5
2.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
432
3461
1.42
6.93
5.2
4.7
ng/l
44.6
59.8
1.17
330
2811
(3032080) INR in Blood by Coagulation assay
464
3766
1.41
6.91
12.8
12.7
inr
1.5
1.4
0.24
114
982
(3000991) Gas panel - Venous blood
126
774
1.71
6.87
4.7
6.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
17
40
4.30
6.76
1.4
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
378
2972
1.42
6.68
3.0
2.9
ug/l
117.0
152.8
4.24
341
2650
(3044889) 12 lead EKG panel
577
4893
1.39
6.50
4.5
4.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
64
323
2.04
6.45
2.0
2.2
ug/l
1240.1
674.5
0.31
57
303
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
263
1959
1.46
6.16
2.7
2.7
u/l
31.1
36.8
2.16
236
1848
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
8
12.60
6.09
6.0
1.6
u/field
0.3
1.1
—
10
8
(3014576) Chloride [Moles/volume] in Serum or Plasma
166
1128
1.56
6.04
5.0
5.9
mmol/l
104.0
104.0
0.05
160
1098
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
307
2373
1.41
5.83
2.3
2.3
u/l
54.4
58.6
0.87
282
2177
(42870588) Differential panel, method unspecified - Blood
313
2440
1.40
5.63
4.0
5.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
136
898
1.59
5.59
4.5
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
206
1499
1.46
5.38
2.0
2.4
umol/l
10.1
11.3
1.64
182
1372
(3004789) Transferrin [Mass/volume] in Serum or Plasma
192
1388
1.47
5.18
2.0
2.5
g/l
2.2
2.2
0.47
175
1263
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
151
1044
1.52
5.06
3.8
3.3
ng/l
369.4
319.8
0.47
145
953
(3012095) Magnesium [Moles/volume] in Serum or Plasma
182
1311
1.47
4.99
1.9
2.6
mmol/l
0.8
0.8
0.01
152
1193
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
105
673
1.62
4.89
3.1
3.6
ng/l
90.3
102.5
0.88
84
564
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
37
3.82
4.82
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
154
1081
1.50
4.80
4.4
5.8
mmol/l
1.6
1.4
0.23
127
822
(3044640) Blood type and Crossmatch panel - Blood
311
2483
1.36
4.70
2.2
2.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
93
585
1.65
4.67
3.4
2.9
g/l
127.1
124.1
0.76
93
570
(3022217) INR in Platelet poor plasma by Coagulation assay
207
1550
1.42
4.60
35.5
33.5
inr
1.8
1.6
0.93
29
194
(3052851) Hemolysis interference index of Serum or Plasma
53
286
1.90
4.49
4.2
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
704
6342
1.33
4.47
4.6
5.3
mmol/l
6.3
6.2
0.97
640
5530
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
30
4.03
4.44
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
919
0.55
4.31
4.0
4.8
%
36.0
33.9
0.74
44
583
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
178
1313
1.43
4.28
2.1
2.5
%
18.5
20.2
1.07
137
1116
(3019230) Fractional oxyhemoglobin in Venous blood
30
133
2.29
4.25
1.5
2.1
%
55.3
60.5
0.58
30
133
(3027945) Reticulocytes/100 erythrocytes in Blood
169
1239
1.43
4.21
2.0
2.3
%
1.7
1.8
1.13
139
1084
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
41
3.45
4.19
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
683
6165
1.30
4.05
7.0
6.9
mmol/mol
43.6
41.9
2.90
632
5513
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
150
1083
1.45
4.05
4.3
5.8
kpa
5.0
5.1
0.14
143
1015
(3027801) Oxygen [Partial pressure] in Arterial blood
150
1084
1.45
4.03
4.3
5.8
kpa
10.5
11.4
1.45
143
1016
(3029937) Albumin [Presence] in Urine by Test strip
245
1926
1.35
4.02
6.8
4.8
estimate
0.0
0.0
0.00
52
625
(3021589) Normoblasts [#/volume] in Blood
357
2975
1.30
3.88
8.9
10.7
e9/l
0.0
0.0
1.79
253
2413
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
324
2666
1.31
3.86
7.3
4.9
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
134
2.20
3.76
1.7
1.9
umol/l
34.9
33.7
0.07
20
103
(3036481) Cortisol [Moles/volume] in Serum or Plasma
87
573
1.56
3.66
1.9
1.8
nmol/l
374.3
388.9
0.29
80
502
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
193
1493
1.36
3.49
1.7
1.6
mg/l
1.3
1.6
1.14
160
1159
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
95
2.34
3.35
2.6
2.3
u/field
2.0
2.8
0.24
13
19
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
112
1543
0.69
3.34
1.4
1.6
mmol/l
1.3
1.2
0.76
104
1255
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
32
3.46
3.34
2.8
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
32
3.46
3.34
2.8
2.6
—
—
—
0
0
(4035726)
36
646
0.54
3.33
1.3
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
36
190
1.93
3.32
1.3
1.3
mmol/l
66.0
60.2
0.47
28
150
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
103
722
1.47
3.26
1.6
1.9
g/l
0.2
0.2
0.08
93
661
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
78
2.46
3.23
2.2
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
24
110
2.21
3.20
1.8
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
151
1145
1.37
3.09
2.1
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
388
3348
1.25
3.02
3.1
3.4
ng/l
2417.5
2296.9
0.18
330
2952
(3011648) Oxygen content in Venous blood
16
63
2.56
2.96
1.6
1.3
%
10.0
10.6
0.21
16
63
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
114
2.13
2.96
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
164
1.92
2.87
3.5
2.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
47
2.79
2.82
1.5
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
93
659
1.45
2.81
3.1
3.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
196
1.81
2.74
1.5
2.0
g/l
126.2
120.4
0.64
28
137
(46235355) HIV 1 and 2 tests - Meaningful Use set
68
458
1.52
2.65
1.3
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
47
292
1.64
2.58
1.8
2.5
g/l
0.1
0.0
0.42
39
256
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
21
3.83
2.46
1.1
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
112
842
1.37
2.44
5.1
6.5
g/l
118.6
118.3
0.07
112
813
(1761868) Lipid panel - Serum or Plasma
116
1509
0.74
2.43
4.2
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
680
6311
1.22
2.41
4.7
5.3
mmol/l
2.3
2.4
5.39
626
5556
(3019832) Treponema pallidum Ab [Presence] in Serum
22
111
2.00
2.37
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
22
3.66
2.36
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
328
2843
1.22
2.34
4.3
5.9
ug/l
2.2
6.2
1.88
289
2477
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
268
2284
1.23
2.25
4.0
5.1
%
24.7
22.4
1.30
135
1246
(21494755) Public health laboratory ask at order entry panel
0
62
0.00
2.22
0.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
60
2.35
2.22
1.2
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
14
4.30
2.15
1.7
1.2
—
—
—
0
0
(4034850)
35
214
1.66
2.09
17.0
13.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
408
1.47
2.08
2.2
2.2
g/l
3.9
3.7
0.52
37
282
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
410
1.46
2.03
2.2
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
145
1165
1.28
2.02
4.4
4.6
mmol/l
1.1
1.0
0.49
125
1071
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
411
1.46
2.01
2.2
2.2
g/l
7.9
7.6
0.43
37
295
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
50
339
1.50
1.95
2.4
2.5
g/l
1.4
1.1
0.19
40
276
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
22
3.20
1.88
1.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
69
502
1.40
1.88
5.0
7.6
mmol/l
24.4
24.7
0.27
62
456
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
42
277
1.54
1.87
1.8
2.6
g/l
0.0
0.0
0.00
34
244
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
43
286
1.52
1.84
2.9
2.6
pmol/l
4.2
4.3
0.26
33
247
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
42
279
1.53
1.82
1.8
2.6
g/l
0.0
0.0
0.00
34
244
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
184
1.65
1.80
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
543
0.65
1.78
3.2
3.7
%
0.4
0.6
—
7
152
(3043409) Potassium [Moles/volume] in Arterial blood
41
273
1.52
1.76
3.3
3.5
mmol/l
3.9
4.0
0.21
35
247
(40768804) Tissue Pathology biopsy report
237
2729
0.83
1.76
2.1
2.5
—
—
—
0
0
(4027681)
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
204
2381
0.82
1.74
3.1
3.1
mg/l
799.2
238.3
0.68
153
1533
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
186
1.63
1.73
1.1
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
382
1.44
1.73
2.3
2.3
g/l
3.3
3.3
0.01
37
290
(3014891) Appearance of Pleural fluid
7
24
2.93
1.72
1.9
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
187
1.62
1.70
1.1
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
15
75
2.01
1.70
1.1
1.1
mmol/l
33.6
32.8
—
9
63
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
204
1.59
1.67
4.9
4.1
mg/l
32.4
33.2
0.03
23
139
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
25
2.81
1.65
1.9
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
205
1.58
1.64
1.1
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
137
1.69
1.56
1.7
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
117
949
1.26
1.54
2.3
2.7
ug/l
4.9
6.3
0.99
92
799
(3000475) Leukocytes [#/volume] in Synovial fluid
29
185
1.58
1.52
1.7
1.6
e6/l
26251.4
16908.9
0.29
20
127
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
393
1.39
1.51
2.1
2.4
u/ml
0.3
0.4
0.15
27
231
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
51
2.17
1.51
1.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
45
2.23
1.46
2.8
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
210
1826
1.19
1.42
7.2
4.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
15
81
1.86
1.40
1.2
2.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
382
1.38
1.39
2.3
2.3
g/l
10.4
10.3
0.06
40
313
(3051651) Icteric interference index of Serum or Plasma
11
53
2.09
1.38
2.7
3.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
60
2.01
1.38
1.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
82
1.84
1.36
1.0
1.3
mosm/kgh2o
277.4
271.7
—
8
60
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
91
731
1.27
1.33
3.1
3.7
mmol/l
1.2
1.2
0.58
81
629
(3023383) Lactate [Moles/volume] in Pleural fluid
0
40
0.00
1.33
0.0
1.4
—
3.2
—
0
35
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
98
1.75
1.31
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
483
0.69
1.30
1.2
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
44
319
1.40
1.29
1.8
2.4
g/l
35.4
36.4
0.63
35
260
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
410
0.67
1.26
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
117
0.42
1.25
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
326
0.64
1.25
3.0
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
60
772
0.76
1.24
1.2
1.2
u/ml
1.8
13.4
—
9
244
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
129
1087
1.21
1.23
3.1
3.5
u/l
254.2
252.4
0.04
112
1017
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
10
49
2.05
1.22
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
453
0.70
1.21
3.8
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
56
428
1.33
1.20
2.9
3.3
e9/l
3.9
4.2
0.36
39
279
(1616796) Gas panel - Central venous blood
30
206
1.47
1.18
1.9
4.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
102
1.68
1.16
1.2
1.2
nmol/l
0.7
0.8
0.30
12
82
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
475
1.30
1.15
6.3
7.8
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
35
0.00
1.15
0.0
1.3
—
83.8
—
0
15
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
64
502
1.29
1.15
1.4
1.7
g/l
1.4
1.5
0.31
52
425
(3020630) Protein [Mass/volume] in Serum or Plasma
102
847
1.23
1.14
2.4
2.4
g/l
65.6
65.6
0.01
86
755
(3020779) Urea [Moles/volume] in Serum or Plasma
101
839
1.23
1.12
4.5
5.4
mmol/l
11.8
12.6
0.45
90
789
(3006653) Thiamine [Moles/volume] in Blood
7
30
2.34
1.12
1.0
1.0
nmol/l
122.7
133.6
—
7
30
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
40
2.01
1.12
1.4
2.5
—
—
—
0
0
(4010399)
34
468
0.72
1.11
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
47
614
0.75
1.10
3.0
3.9
%
0.5
0.9
0.96
16
215
(3006270) Folate [Moles/volume] in Blood
15
89
1.70
1.08
1.6
1.2
nmol/l
295.4
340.0
—
9
73
(3021440) Promyelocytes/100 leukocytes in Blood
44
578
0.75
1.07
3.0
3.9
%
0.0
0.1
4.33
14
199
(3037756) Immunofixation for Serum or Plasma
33
236
1.41
1.07
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
392
1.32
1.07
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
74
1.77
1.07
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
74
1.77
1.07
1.2
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
364
3361
1.13
1.07
4.0
4.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
34
245
1.40
1.06
5.8
3.2
mmol/l
8.0
7.9
0.11
34
239
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
80
972
0.81
1.05
2.5
3.6
ug/l
3.4
24.4
1.97
68
836
(40768797) Stomach Pathology biopsy report
76
927
0.81
1.04
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
36
483
0.74
1.02
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
673
0.78
1.02
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
60
476
1.28
1.01
5.7
3.7
%
48.4
47.1
0.18
60
469
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
61
1.81
0.98
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
310
1.34
0.98
7.9
4.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
30
0.00
0.97
0.0
1.6
—
4.4
—
0
16
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
158
1.47
0.94
2.0
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
35
262
1.35
0.90
5.7
3.1
mmol/l
1.5
1.7
1.14
35
257
(40768443) Skin Pathology biopsy report
25
346
0.72
0.88
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
128
0.54
0.88
2.3
3.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
180
0.61
0.86
1.3
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
215
2364
0.89
0.85
2.9
3.1
mmol/l
6.8
6.4
0.82
185
1879
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
96
1.57
0.84
1.1
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
401
1.26
0.81
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
305
0.72
0.80
2.9
2.2
—
—
—
0
0
(3013512) EKG study
227
2478
0.89
0.80
5.4
4.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
520
1.22
0.80
2.7
2.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
48
1.67
0.79
1.8
5.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
340
1.28
0.78
2.1
3.3
mg/l
84.2
51.8
0.36
37
276
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
122
0.57
0.78
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
115
1.49
0.77
2.9
3.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
341
1.27
0.77
2.1
3.3
mg/l
48.7
92.5
1.19
37
273
(3012501) Base excess in Blood by calculation
30
226
1.34
0.77
2.7
4.8
mmol/l
1.8
2.7
2.02
23
142
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
206
1876
1.12
0.76
2.1
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
34
1.77
0.76
2.5
3.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
38
297
1.29
0.76
2.1
2.5
—
5.7
—
0
8
(3035637) Corticotropin [Mass/volume] in Plasma
9
53
1.70
0.75
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
85
728
1.18
0.74
2.4
2.3
—
—
—
0
0
(3010421) pH of Blood
34
263
1.30
0.74
2.7
4.5
ph
7.4
7.4
0.21
29
220
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
25
2.00
0.72
1.6
1.7
nmol/l
0.4
0.8
—
5
19
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
68
1.62
0.72
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
84
969
0.86
0.68
13.0
9.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
180
0.66
0.68
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
66
560
1.19
0.66
6.3
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
235
2532
0.91
0.65
3.6
3.9
mg/mmol
12.3
10.1
0.41
172
1593
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
166
0.66
0.65
1.1
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
380
0.78
0.63
2.1
2.1
nmol/l
10.0
10.8
0.17
30
316
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
79
1.52
0.62
1.2
1.4
—
57.8
—
0
9
(3051611) Lipemic interference index of Serum or Plasma
16
113
1.42
0.61
2.8
3.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
83
724
1.16
0.61
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
530
0.82
0.60
2.7
3.9
%
0.0
0.2
—
10
162
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
22
0.00
0.59
0.0
1.1
—
1.1
—
0
12
(3020891) Body temperature
45
373
1.22
0.58
3.4
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
626
6065
1.08
0.58
3.9
4.6
mmol/l
4.1
4.3
3.83
563
5389
(3021901) Oxygen saturation in Capillary blood
25
193
1.30
0.58
1.9
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
106
1.42
0.58
1.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
73
834
0.87
0.55
1.2
1.2
iu/ml
29.0
38.7
0.23
16
265
(40768793) Breast Pathology biopsy report
8
126
0.63
0.54
1.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
222
1.27
0.54
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
39
469
0.83
0.54
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
259
1.24
0.53
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
1.1
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
1.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
120
1089
1.11
0.51
1.3
1.2
u/ml
4.6
1.7
0.49
26
252
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.1
1.6
—
—
—
0
0
(3019225) pH of Specimen
75
845
0.88
0.48
4.1
4.7
—
—
—
0
0
(44806420)
7
46
1.53
0.48
2.3
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
93
1.40
0.48
1.5
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
174
1620
1.09
0.45
2.8
3.5
ug/l
0.8
0.9
1.18
136
1165
(4062490)
7
50
1.40
0.45
1.3
1.3
—
—
—
0
0
(4094501)
10
141
0.71
0.45
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
127
0.71
0.43
4.8
3.0
e9/l
4.8
4.8
—
9
127
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
615
5994
1.06
0.43
3.8
4.6
mmol/l
1.4
1.4
0.82
550
5251
(36660697) Celiac disease serology panel - Serum
43
369
1.17
0.42
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.6
—
0.1
—
0
10
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
22
177
1.25
0.40
1.3
2.2
mg/l
1.6
2.0
0.87
15
151
(3000285) Sodium [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
18
0.00
0.40
0.0
2.0
—
2.7
—
0
5
(3008536) Aspergillus sp Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
160
0.75
0.40
2.0
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
102
0.68
0.39
3.0
4.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
101
0.69
0.39
2.6
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
158
1476
1.08
0.39
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
193
0.77
0.39
3.6
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.1
—
0.8
—
0
7
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
68
1.33
0.37
15.2
21.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
268
0.82
0.37
1.3
2.9
u/ml
216.7
93.7
0.28
22
263
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
189
1.22
0.36
2.0
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
85
930
0.91
0.36
1.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
30
254
1.19
0.35
2.4
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
172
1.23
0.34
1.0
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
100
1.30
0.33
1.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
360
0.86
0.33
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
88
0.68
0.33
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
90
0.66
0.33
1.2
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
119
1.26
0.32
1.1
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
131
0.76
0.31
4.4
3.6
%
55.2
62.7
—
10
131
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
131
0.76
0.31
1.0
1.1
—
26.3
—
0
10
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
142
0.77
0.31
1.2
1.1
—
88.0
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
16
129
1.24
0.30
1.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
55
1.27
0.30
1.4
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
56
1.25
0.29
2.3
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
241
1.17
0.29
1.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
135
1272
1.07
0.29
4.5
4.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
57
1.23
0.29
2.9
4.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
575
0.90
0.28
3.0
3.7
mmol/l
2.4
2.2
0.09
36
412
(3023419) Bacteria identified in Sputum by Culture
9
116
0.77
0.27
1.4
2.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
1.1
1.2
nmol/l
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
8
64
1.25
0.27
4.0
3.4
mmol/l
9.4
7.3
—
8
42
(3004616) Nuclear Ab [Presence] in Serum
5
74
0.67
0.26
1.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
207
1988
1.05
0.25
2.8
2.9
umol/l
4373.5
9675.8
0.99
175
1622
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
76
1.19
0.24
1.1
2.1
—
1650.4
—
0
10
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
199
1.16
0.23
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
106
1000
1.07
0.23
1.5
1.4
g/l
3.4
2.7
1.09
55
541
(3048689) Calprotectin [Mass/mass] in Stool
47
515
0.91
0.23
1.6
1.8
ug/g
218.3
172.6
0.39
36
385
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
56
608
0.92
0.23
3.0
3.7
kpa
5.3
5.2
0.16
49
556
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
93
0.75
0.22
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
326
0.89
0.22
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
589
5798
1.04
0.21
3.6
4.2
mmol/l
1.2
1.2
0.08
515
5030
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
98
1.23
0.21
1.0
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
44
402
1.10
0.21
1.7
1.8
ug/l
0.8
3.4
1.53
39
333
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.0
—
10.5
—
0
6
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
29.3
—
0
9
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
2.9
—
0
7
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
2.0
—
0
14
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
97
920
1.06
0.19
2.5
2.3
e9/l
65.4
67.9
0.30
74
720
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
366
1.10
0.19
4.3
3.3
nmol/l
0.8
0.8
0.31
30
287
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
109
1.20
0.18
1.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
7
59
1.19
0.18
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
60
1.17
0.18
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
60
1.17
0.18
1.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
61
1.15
0.17
1.6
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
56
598
0.93
0.17
2.9
3.8
ph
7.4
7.4
—
10
60
(40768795) Lymph node Pathology biopsy report
5
70
0.71
0.16
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
69
1.16
0.16
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
120
1.17
0.16
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
76
721
1.06
0.16
4.0
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
73
1.10
0.15
1.6
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
6
76
0.79
0.15
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
54
507
1.07
0.15
7.5
4.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
121
1.16
0.15
1.3
1.4
—
—
—
0
0
(4024509)
9
81
1.11
0.15
1.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
82
1.10
0.15
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
244
0.90
0.14
1.1
1.2
iu/ml
50.9
129.1
—
7
76
(3023199) Leukocytes [#/volume] in Pleural fluid
19
169
1.13
0.14
1.4
1.4
e6/l
1318.9
1594.8
—
10
124
(21494434) Karyotype in Bone marrow
7
89
0.79
0.14
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
151
1.13
0.13
1.4
1.3
e6/l
124702.0
74975.0
—
9
92
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
211
0.90
0.13
1.8
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
85
1.18
0.12
2.6
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
331
0.93
0.10
2.4
2.9
u/ml
60.0
9849.3
0.65
24
275
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
164
1.10
0.09
1.1
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
46
1.09
0.09
1.2
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
563
0.96
0.09
3.1
3.2
ml/min/173m2
56.3
53.7
0.21
21
274
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
54
1.11
0.09
1.0
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
57
1.05
0.08
1.7
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
6
58
1.03
0.08
2.2
1.3
%
22.6
23.5
—
6
39
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
1.0
1.1
g/l
1.6
1.7
—
5
60
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
17
156
1.09
0.08
1.2
1.6
iu/ml
28.6
0.5
—
7
46
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
68
1.03
0.08
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
215
0.93
0.07
1.5
1.5
ug/g
157.7
257.4
1.69
11
131
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
408
0.95
0.07
2.1
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
78
1.03
0.07
2.6
3.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
86
1.05
0.07
1.3
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
64
660
0.97
0.07
1.2
1.2
titre
560.0
557.2
0.00
13
156
(1002224) Polysomnography panel
11
99
1.11
0.06
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
104
0.86
0.06
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
105
0.86
0.06
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
105
0.86
0.06
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
296
1.05
0.06
1.6
2.7
g/l
0.6
0.3
0.44
11
111
(3049717) Cytology report of Urine Cyto stain
44
426
1.03
0.05
2.5
3.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
38
367
1.04
0.04
2.1
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
130
1.08
0.04
1.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
113
1.06
0.02
1.3
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
133
1.05
0.01
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
106
0.94
0.01
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
124
1.05
0.00
1.6
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
104
0.96
0.00
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
194
0.98
0.00
1.7
2.5
ug/min
612.9
79.2
—
7
117
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
26
264
0.98
0.00
1.6
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
138
1.01
0.00
1.5
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
193
0.98
0.00
2.0
2.3
%
16.8
15.0
—
8
91
(40761536) Microorganisms panel - Urine sediment
62
619
1.00
0.00
6.0
4.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
175
0.97
0.00
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
105
0.95
0.00
1.3
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
59
0.85
0.00
1.8
2.0
ug/l
3.3
3.0
—
5
54
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
93
0.97
0.00
1.2
1.1
—
34.4
—
0
9
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
68
0.88
0.00
1.7
1.2
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
63
0.95
0.00
2.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
(44790049)
7
73
0.96
0.00
1.1
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
97.7
—
0
6
(40768806) Pleura Pathology biopsy report
15
150
1.00
0.00
1.4
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
7
73
0.96
0.00
1.1
1.4
—
—
—
0
0
(44790048)
7
73
0.96
0.00
1.1
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
7
73
0.96
0.00
1.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
1.9
—
0
8
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
1.0
—
0
8
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint VD_SC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_SC | 2.216 [1.92, 2.56] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 3411 out of 5576 females with VD_SC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_SC | 2.752 [2.26, 3.34] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 2589 out of 3954 males with VD_SC died.
Mortality risk
Mortality risk for people of age
years, who have VD_SC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.19% | 0.439% |
| 5 | 0.887% | 2.567% |
| 10 | 2.593% | 6.823% |
| 15 | 5.147% | 12.85% |
| 20 | 8.771% | 21.239% |
Relationships between endpoints
↥Index endpoint: VD_SC – Vascular dementia (subcortical)
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data